New $1 testing bundle targets HIV, syphilis and hepatitis B screening
A new commercial testing package priced at $1 per woman is being promoted for antenatal screening for HIV, syphilis and hepatitis B, with Nigeria identified as a potential high-volume market. Modelling projects large savings if widely adopted, but the companies stress that actual results will depend on uptake and implementation.
Nigeria has been identified as one of several high-volume markets where a new $1 testing package could help expand antenatal screening for HIV, syphilis and hepatitis B. Premier Medical Corporation and Impact Nexus Africa said their Triple Elimination Testing Bundle combines two rapid diagnostic tests under one commercial offer for use through existing antenatal care services. The package costs $1 ex-works per woman screened.
It includes a World Health Organisation-prequalified test that screens for HIV and syphilis simultaneously, alongside a separate test for a hepatitis B surface-antigen marker. Digital training and competency tools are included. The price excludes freight, local distribution, taxes, regulatory charges and other implementation costs.
Purchasers must order at least 100,000 bundles, and availability remains subject to national registration, importation and procurement requirements. The companies estimate that the package could produce about $215 million in commodity savings across 74 low- and middle-income countries between 2026 and 2035. They say it is 22 to 46 per cent cheaper in commodity terms than buying equivalent tests separately.
The estimates are based on modelling and do not represent confirmed savings for Nigeria or any other individual country. Actual results would depend on procurement prices, testing volumes, screening uptake and the pace of implementation. Nigeria’s need is linked to limited hepatitis B screening during pregnancy.
A 2026 analysis of Demographic and Health Survey data found that 72 per cent of mothers attended antenatal care, but only 12.3 per cent were tested for hepatitis B. Earlier analysis found screening among 7.2 per cent of about 2.8 million women receiving antenatal care at relevant facilities. The companies said the package could help expand screening through existing services.
The Federal Ministry of Health and Social Welfare has also been working to strengthen hepatitis B testing as part of Nigeria’s effort to prevent mother-to-child transmission.
This independently written report is based on information supplied by the named publisher. Vertrix News has not independently verified the source report.